Literature DB >> 18687282

The role of analgesics and intra-articular injections in disease management.

William F Harvey1, David J Hunter.   

Abstract

The focus of pharmacologic treatment of osteoarthritis (OA) includes targets from the cell and cytokine level to the larger joint components such as cartilage, bone, innervations, and vascular supply. The most important goals of therapy in patients who have OA are pain management, improvement in function and disability, and ultimately disease modification. This article discusses the current pharmacologic regimens available to address these goals. Specific attention is paid to current trends and controversies related to pharmacologic management, including the use of oral, topical, and injectable agents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18687282     DOI: 10.1016/j.rdc.2008.05.006

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  13 in total

1.  Current evidence for osteoarthritis treatments.

Authors:  Ananthila Anandacoomarasamy; Lyn March
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-02       Impact factor: 5.346

Review 2.  Management of chronic arthritis pain in the elderly.

Authors:  Mary-Ann Fitzcharles; David Lussier; Yoram Shir
Journal:  Drugs Aging       Date:  2010-06-01       Impact factor: 3.923

3.  The evaluation of the effectiveness of intra-articular steroid, tenoxicam, and combined steroid-tenoxicam injections in the treatment of patients with knee osteoarthritis.

Authors:  Ebru Yilmaz
Journal:  Clin Rheumatol       Date:  2019-06-26       Impact factor: 2.980

4.  Comparison of the efficacy of bone marrow mononuclear cells and bone mesenchymal stem cells in the treatment of osteoarthritis in a sheep model.

Authors:  Fanglong Song; Jilei Tang; Rui Geng; Hansheng Hu; Chunhui Zhu; Weiding Cui; Weimin Fan
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

5.  Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis.

Authors:  Giuseppe Filardo; Elizaveta Kon; Roberto Buda; Antonio Timoncini; Alessandro Di Martino; Annarita Cenacchi; Pier Maria Fornasari; Sandro Giannini; Maurilio Marcacci
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-08-26       Impact factor: 4.342

Review 6.  Evidence-based radiology (part 2): Is there sufficient research to support the use of therapeutic injections into the peripheral joints?

Authors:  Cynthia Peterson; Juerg Hodler
Journal:  Skeletal Radiol       Date:  2009-08-29       Impact factor: 2.199

7.  Characterisation of a peripheral neuropathic component of the rat monoiodoacetate model of osteoarthritis.

Authors:  Matthew Thakur; Wahida Rahman; Carl Hobbs; Anthony H Dickenson; David L H Bennett
Journal:  PLoS One       Date:  2012-03-21       Impact factor: 3.240

8.  Comparative effectiveness of B and e vitamins with diclofenac in reducing pain due to osteoarthritis of the knee.

Authors:  Morteza Dehghan
Journal:  Med Arch       Date:  2015-04-06

Review 9.  A Review of Topical Diclofenac Use in Musculoskeletal Disease.

Authors:  Bindu Nair; Regina Taylor-Gjevre
Journal:  Pharmaceuticals (Basel)       Date:  2010-06-11

10.  Do preoperative intra-articular corticosteroid and hyaluronic acid injections affect time to total joint arthroplasty?

Authors:  Alex Tang; Omar Almetwali; Stephen G Zak; Jenna A Bernstein; Ran Schwarzkopf; Vinay K Aggarwal
Journal:  J Clin Orthop Trauma       Date:  2021-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.